(RTTNews) - Ascletis Pharma Inc. (1672.HK) reported positive Phase 1 results for ASC50 in plaque psoriasis, with the investigational oral therapy showing a 48.9% placebo-adjusted reduction in PASI score after 28 days of treatment.
(RTTNews) - FMC Corp. (FMC), an agricultural sciences company, announced the submission of the regulatory dossier for rimisoxafen, an herbicide active ingredient, to Brazilian regulatory authorities.
(RTTNews) - Corteva, Inc. (CTVA) and Inari, the SEEDesign company, have reached a confidential settlement agreement to resolve a lawsuit filed by Corteva in September 2023 in the U.S. District Court for the District of Delaware.
(RTTNews) - Stock markets in Europe are expected to open on a mildly positive note on Tuesday. However, sentiment is likely to be impacted by the surge in crude oil prices and the spike in bond yields. Worries about artificial intelligence is also expected to weigh on sentiment.
(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA) announced that the U.S. Food and Drug Administration (FDA) has approved DEGEVMA as a biosimilar to Xgeva (denosumab).
(RTTNews) - Australian online real estate advertising company REA Group Limited (REA.AX, RPGRF) announced Tuesday its agreement to acquire a 35% non-controlling minority interest in Distilled Ltd, a vertical digital marketplace operator across Ireland and Northern Ireland, for €2